Plasma Alpha-1-glycoprotein (AGP) binds diverse drugs, its isoforms and their levels vary significantly in acute phases of health. Relative binding pattern of drugs to AGP and albumin has been used to model their release profiles, and structural insights on glycosylated form of AGP will improve predictions. Main challenge is the heavy and heterogeneous glycosylation of AGP molecules. Our small angle X-ray scattering (SAXS) data on plasma extracted AGP showed interparticulate effect from 283 to 313 K which disappeared irreversibly upon further heating to 343K. Using ALPHAFOLD2 server, the protein only portion could be modelled but as expected its theoretical SAXS profile did not match acquired experimental data. Using mass spectra-based information, we attached representative glycan motifs at known sites to compute four models of fully glycosylated AGP. Importantly, calculated SAXS profiles of these models agreed with our experimental data. These representative glycosylated models were further analyzed for molecular motions using Normal Mode Analysis and all-atom Molecular Dynamics simulations in reference to SAXS data. Overall, we show that SAXS data-based models of glycoprotein are better representation of this biopharmaceutical molecule and provide them for structure-based drug profile estimations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/07391102.2025.2475244 | DOI Listing |
Cells
March 2025
College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.
Ataxin-2 (Atx2), an RNA-binding protein, plays a pivotal role in the regulation of RNA, intracellular metabolism, and translation within the cellular environment. Although both the Sm-like (LSm) and LSm-associated (LSmAD) domains are considered to associated with RNA binding, there is still a lack of experimental evidence supporting their functions. To address this, we designed and constructed several recombinants containing the RNA-binding domain (RBD) of Atx2.
View Article and Find Full Text PDFNucleic Acids Res
February 2025
Protein-Nucleic Acid Interaction Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, United States.
Synthetic RNA devices are engineered to control gene expression and offer great potential in both biotechnology and clinical applications. Here, we present multidisciplinary structural and biochemical data for a tetracycline (Tc)-responsive RNA device (D43) in both ligand-free and bound states, providing a structure-dynamical basis for signal transmission. Activation of self-cleavage is achieved via ligand-induced conformational and dynamical changes that stabilize the elongated bridging helix harboring the communication module, which drives proper coordination of the catalytic residues.
View Article and Find Full Text PDFJ Biomol Struct Dyn
March 2025
CSIR-Institute of Microbial Technology, Chandigarh, India.
Plasma Alpha-1-glycoprotein (AGP) binds diverse drugs, its isoforms and their levels vary significantly in acute phases of health. Relative binding pattern of drugs to AGP and albumin has been used to model their release profiles, and structural insights on glycosylated form of AGP will improve predictions. Main challenge is the heavy and heterogeneous glycosylation of AGP molecules.
View Article and Find Full Text PDFJ Chem Phys
March 2025
MIREA - Russian Technological University, Lomonosov Institute of Fine Chemical Technologies, 86, Prospekt Vernadskogo, Moscow 119571, Russia.
The behavior of silver nitrate in non-aqueous liquid oligomeric media-aromatic and aliphatic diglycidyl ethers and aliphatic diamine-has been investigated. By employing UV-visible spectrophotometry and dynamic light scattering, it has been shown that in diglycidyl oligomers, regardless of the nature of the monomeric unit, the formation of silver nanoparticles occurs, and the kinetics of this process has been studied. At the same time, in the medium of aliphatic diamine, the reduction of silver ions is absent, indicating the formation of a complex compound.
View Article and Find Full Text PDFElife
March 2025
Department of Bioscience, University of Milan, Milan, Italy.
Both immunoglobulin light-chain (LC) amyloidosis (AL) and multiple myeloma (MM) share the overproduction of a clonal LC. However, while LCs in MM remain soluble in circulation, AL LCs misfold into toxic-soluble species and amyloid fibrils that accumulate in organs, leading to distinct clinical manifestations. The significant sequence variability of LCs has hindered the understanding of the mechanisms driving LC aggregation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!